Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
Apple
AAPL
|
+$935M |
| 3 |
Warner Bros
WBD
|
+$783M |
| 4 |
Home Depot
HD
|
+$626M |
| 5 |
Amazon
AMZN
|
+$476M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$734M |
| 2 |
CERN
Cerner Corp
CERN
|
+$600M |
| 3 |
Marathon Petroleum
MPC
|
+$180M |
| 4 |
PBCT
People's United Financial Inc
PBCT
|
+$169M |
| 5 |
S&P Global
SPGI
|
+$163M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.76% |
| 3 | Financials | 13.17% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBP
4126
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $254K | ﹤0.01% |
+14,688
| New | +$240K |
|
4127
Ark Restaurants
ARKR
$20.2M
| $253K | ﹤0.01% |
14,060
+1,479
| +12% | +$25.6K |
|
4128
Crown Crafts
CRWS
$32M
| $253K | ﹤0.01% |
40,540
+20,452
| +102% | +$128K |
|
4129
Dominari Holdings
DOMH
$70.8M
| $253K | ﹤0.01% |
43,100
-5
| -0% | -$29 |
|
|
ATXS
4130
DELISTED
Astria Therapeutics
ATXS
| $252K | ﹤0.01% |
84,196
+6,089
| +8% | +$27.3K |
|
4131
Intercorp Financial Services
IFS
$6.09B
| $251K | ﹤0.01% |
10,730
| – | – |
|
4132
Rocky Mountain Chocolate Factory
RMCF
$14.3M
| $251K | ﹤0.01% |
36,484
+22,946
| +169% | +$154K |
|
|
BIOL
4133
DELISTED
Biolase, Inc.
BIOL
| $251K | ﹤0.01% |
549
+20
| +4% | +$11K |
|
4134
POSCO
PKX
$17.3B
| $250K | ﹤0.01% |
5,621
+1,475
| +36% | +$81.2K |
|
|
LUMO
4135
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $250K | ﹤0.01% |
32,502
+429
| +1% | +$3.43K |
|
4136
Corbus Pharmaceuticals
CRBP
$189M
| $249K | ﹤0.01% |
32,947
-2,612
| -7% | -$25.2K |
|
4137
Theriva Biologics
TOVX
$11M
| $248K | ﹤0.01% |
4,663
+151
| +3% | +$8.64K |
|
|
TTOO
4138
DELISTED
T2 Biosystems, Inc
TTOO
| $248K | ﹤0.01% |
308
-8
| -3% | -$11.9K |
|
4139
Jasper Therapeutics
JSPR
$27.4M
| $246K | ﹤0.01% |
12,773
| – | – |
|
|
NBSE
4140
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $246K | ﹤0.01% |
11,729
-470
| -4% | -$11K |
|
|
CDTX
4141
DELISTED
Cidara Therapeutics
CDTX
| $245K | ﹤0.01% |
25,102
+1,298
| +5% | +$16K |
|
4142
Frequency Electronics
FEIM
$858M
| $245K | ﹤0.01% |
33,597
+294
| +0.9% | +$2.26K |
|
4143
Protara Therapeutics
TARA
$219M
| $245K | ﹤0.01% |
83,644
+1,680
| +2% | +$6.14K |
|
4144
Xilio Therapeutics
XLO
$59.5M
| $244K | ﹤0.01% |
5,971
-4,151
| -41% | -$220K |
|
4145
Candel Therapeutics
CADL
$783M
| $243K | ﹤0.01% |
75,217
| – | – |
|
4146
Kewaunee Scientific
KEQU
$104M
| $243K | ﹤0.01% |
14,738
+82
| +0.6% | +$1.17K |
|
4147
Forte Biosciences
FBRX
$1.57B
| $242K | ﹤0.01% |
7,464
-2,811
| -27% | -$89.3K |
|
4148
Sono-Tek
SOTK
$82M
| $242K | ﹤0.01% |
33,250
+584
| +2% | +$3.64K |
|
|
PTRS
4149
DELISTED
Partners Bancorp Common Stock
PTRS
| $242K | ﹤0.01% |
26,867
+247
| +0.9% | +$2.23K |
|
|
CARV
4150
DELISTED
Carver Bancorp
CARV
| $241K | ﹤0.01% |
41,970
-22,432
| -35% | -$178K |
|
Similar funds
Geode Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
- Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
- Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
- Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
- Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
- Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
- Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.
Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.